2022-RA-863-ESGO Slovenian experience with pembrolizumab in patients with metastatic endometrial and cervical cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Miscellaneous

2022-RA-863-ESGO Slovenian experience with pembrolizumab in patients with metastatic endometrial and cervical cancer

Free

Online download statistics by month:

Online download statistics by month: October 2022 to May 2023

	Abstract	Full	Pdf
Oct 2022	24	0	1
Nov 2022	26	0	3
Dec 2022	57	0	7
Jan 2023	18	0	1
Feb 2023	9	0	1
Mar 2023	8	0	1
Apr 2023	8	0	0
May 2023	12	0	1
Total	162	0	15